OpenAI made a series of announcements this week that emphasize its interest in bringing ChatGPT to patients and providers.
California, New Hampshire, Pennsylvania, and South Carolina stopped covering adult GLP-1 prescriptions for obesity on Jan. 1.
City of Hope CEO Robert Stone shares how funding stability, AI fluency and culture are key to retaining the next generation of research talent.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback